- E. coli and Shigella
- Production Status
- Escherichia coli 101-1
- Escherichia coli 53638
- Escherichia coli B171
- Escherichia coli B7A
- Escherichia coli E110019
- Escherichia coli E22
- Escherichia coli E24377A
- Escherichia coli F11
- Escherichia coli HS
- Escherichia coli SECEC SMS-3-5
- Shigella boydii BS512
- Shigella dysenteriae 1012
- References
E. coli and Shigella Genome Project
Goals
The complete genomes of four well-defined E. coli / Shigella strains are being sequenced to closure, in addition to eight genomes at draft coverage, totaling 12 genomes. This work significantly expands and complements the E. coli / Shigella genome projects that are completed or underway worldwide. The number of diseases that the members of these genera can cause underscores their diversity. We are addressing the breadth of this diversity by focusing our sequencing efforts on representative members of three previously under-sequenced groups: enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC) and Shigella boydii, all of which cause significant morbidity and mortality in humans. In addition to these pathogenic isolates, we are sequencing E. coli HS, a strain known to colonize the human gastrointestinal tract without causing disease. This commensal genome sequence will provide a genomic scaffold which will facilitate rapid identification and focused analysis of pathogen-specific genomic islands and allow identification of those factors responsible for colonization which are shared among the pathogenic members of the E. coli / Shigella. This work will increase our understanding of these genera, enabling the development of robust typing schema and identification of new vaccine targets, as well as potentially aid in forensic analysis in cases of bioterrorism.
Isolate Selection
Strain selection was performed after extensive consultation with the E. coli / Shigella scientific community, other agencies funding similar projects. A meeting of an Advisory Committee (see list below) resulted in the selection of the twelve E. coli / Shigella strains targeted for genomic sequencing.
Investigators and Collaborators
Boedeker, Ed C. | Univ. of Maryland School of Medicine and the Center for Vaccine Development |
Brinkley, Carl | Walter Reed Army Institute of Research |
Brinkley, Carl | Walter Reed Army Institute of Research |
University of Maryland | |
Greene, John | SRA |
University of Maryland | |
Univ. of Maryland School of Medicine and the Center for Vaccine Development | |
Uniformed Services University of the Health Sciences | |
Uniformed Services University of the Health Sciences | |
University of Michigan | |
Univ. of Michigan Medical School | |
Myers, Garry | Institute for Genome Sciences, University of Maryland School of Medicine |
University of Maryland | |
Univ. of Maryland School of Medicine | |
Iowa State | |
Uniformed Services University of the Health Sciences | |
University of Wisconsin | |
Rasko, David A. | University of Texas Southwestern Medical Center |
Ravel, Jacques | Institute for Genome Sciences, University of Maryland School of Medicine |
Rosovitz, M.J. | Midwest Research Institute |
Savarino, Stephen J. | Naval Medical Research Center |
Savarino, Stephen J. | Naval Medical Research Center |
Emory | |
Seshadri, Rekha | J. Craig Venter Institute |
Teel, Louise D. | Uniformed Services University of the Health Sciences |
University of Texas Medical Branch | |
University of Wisconsin |

RSS